Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 41 matching records.
41 results — page 1 of 2
- Level DAnimal StudyPubMed
Treatment with Neuronal-Induced Human Mesenchymal Stem Cells Improves Functional Recovery of Acute Spinal Cord Injury through Attenuating Astrogliosis and Neurotoxic Astrocyte Activation.
Animal Study on Spinal Cord Injury, published in J Korean Neurosurg Soc (2026) — summary generated from the PubMed abstract.
- 2026
J Korean Neurosurg Soc - Level DNarrative ReviewEurope PMC
Current status and future prospects of functionalized mesenchymal stem cells for the treatment of spinal cord injury
Narrative Review on Spinal Cord Injury, Chronic Inflammation, published in J Orthop Translat (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Translat - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level DNarrative ReviewEurope PMC
Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases
Narrative Review on Osteoarthritis, Spinal Cord Injury, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DLaboratory StudyEurope PMC
Biomaterial-based strategies: a new era in spinal cord injury treatment
Laboratory Study on Spinal Cord Injury, Neuroinflammation, published in Neural Regen Res (2025) — summary generated from the PubMed abstract.
- 2025
Neural Regen Res9 citations - Level BRandomized Controlled TrialPubMed
Resveratrol pretreatment improved the function of mesenchymal stem cells in the recovery of spinal cord injury by stimulating the secretion of nerve growth factor.
Randomized Controlled Trial on Spinal Cord Injury, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Histol - Level DAnimal StudyPubMed
Spinal Cord Injury Treatment by Applying a Composite Scaffold Transplanted with Mesenchymal Stem Cells and Chitosan-Coated Nanostructured Lipid Carriers of Curcumin.
Animal Study on Spinal Cord Injury, Chronic Inflammation, published in ACS Appl Bio Mater (2025) — summary generated from the PubMed abstract.
- 2025
ACS Appl Bio Mater - Level DNarrative ReviewEurope PMC
Nanocarrier-mediated drug delivery systems for spinal cord injury treatment
Narrative Review on Spinal Cord Injury, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol - Level ASystematic ReviewEurope PMC
Adipocyte-Derived Stem Cells in the Treatment of Spinal Cord Injuries in Animal Models: A Systematic Review
Systematic Review on Spinal Cord Injury, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Insights into Astrogliosis, Inflammation Processes, and Emerging Treatments by Exosome Therapy and Low-Level Laser Therapy for Spinal Cord Injury: A Systematic Review
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in J Lasers Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
J Lasers Med Sci - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review
Narrative Review on Spinal Cord Injury, Chronic Inflammation, published in Chin J Traumatol (2024) — summary generated from the PubMed abstract.
- 2024
Chin J Traumatol12 citations - Level DNarrative ReviewEurope PMC
Molars to Medicine: A Focused Review on the Pre-Clinical Investigation and Treatment of Secondary Degeneration following Spinal Cord Injury Using Dental Stem Cells
Narrative Review on Spinal Cord Injury, Neuroinflammation, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells1 citations - Level AMeta-analysisPubMed
Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury in Rat Models: A Systematic Review and Network Meta-Analysis.
Meta-analysis on Spinal Cord Injury, published in Cell Transplant (2024) — summary generated from the PubMed abstract.
- 2024
Cell Transplant - Level BClinical TrialPubMed
Stem Cells in the Treatment of Spinal Cord Injury: A Review of Currently Registered Clinical Trials.
Clinical Trial with a reported sample of 20 on Spinal Cord Injury, published in World Neurosurg (2024) — summary generated from the PubMed abstract.
- 2024
- n = 20
World Neurosurg - Level DNarrative ReviewEurope PMC
Stem cell and tissue engineering approaches in pressure ulcer treatment
Narrative Review on Spinal Cord Injury, Chronic Wound, published in J Spinal Cord Med (2023) — summary generated from the PubMed abstract.
- 2023
J Spinal Cord Med12 citations - Level DNarrative ReviewEurope PMC
Research progress of hydrogels as delivery systems and scaffolds in the treatment of secondary spinal cord injury
Narrative Review on Spinal Cord Injury, Scar, Chronic Inflammation, published in Front Bioeng Biotechnol (2023) — summary generated from the PubMed abstract.
- 2023
Front Bioeng Biotechnol18 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges
Clinical Trial on Spinal Cord Injury, Chronic Inflammation, published in Front Immunol (2023) — summary generated from the PubMed abstract.
- 2023
Front Immunol65 citations - Level DAnimal StudyPubMed
Combined treatment of high-intensity interval training with neural stem cell generation on contusive model of spinal cord injury in rats.
Animal Study on Spinal Cord Injury, published in Brain Behav (2023) — summary generated from the PubMed abstract.
- 2023
Brain Behav7 citations - Level DAnimal StudyPubMed
The Effect of Collagen and Fibrin Hydrogels Encapsulated with Adipose Tissue Mesenchymal Stem Cell-Derived Exosomes for Treatment of Spinal Cord Injury in a Rat Model.
Animal Study with a reported sample of 6 on Spinal Cord Injury, published in Iran J Biotechnol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 6
Iran J Biotechnol - Level BClinical TrialEurope PMC
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
Clinical Trial on Spinal Cord Injury, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci11 citations - Level AMeta-analysisEurope PMC
Experimental Treatments for Spinal Cord Injury: A Systematic Review and Meta-Analysis
Meta-analysis on Spinal Cord Injury, published in Cells (2022) — summary generated from the PubMed abstract.
- 2022
Cells12 citations - Level BRandomized Controlled TrialEurope PMC
Combined treatment with enteric neural stem cells and chondroitinase ABC reduces spinal cord lesion pathology
Randomized Controlled Trial on Spinal Cord Injury, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cell Res Ther24 citations - Level DNarrative ReviewPubMed
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.
Narrative Review on Spinal Cord Injury, Neuroinflammation, Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol - Level DNarrative ReviewEurope PMC
The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes
Narrative Review on Osteoarthritis, Cardiovascular Disease, Spinal Cord Injury, Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol32 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406